ATTR AMYLOIDOSIS WILD TYPE
Clinical trials for ATTR AMYLOIDOSIS WILD TYPE explained in plain language.
Never miss a new study
Get alerted when new ATTR AMYLOIDOSIS WILD TYPE trials appear
Sign up with your email to follow new studies for ATTR AMYLOIDOSIS WILD TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Spine surgery samples could reveal silent heart disease
Diagnosis Recruiting nowThis study looks at tissue removed during back surgery to find early signs of a heart condition called ATTR cardiac amyloidosis. Researchers will test spine samples from 1,663 older adults for abnormal protein deposits. If found, participants will get further heart tests to confi…
Matched conditions: ATTR AMYLOIDOSIS WILD TYPE
Sponsor: Columbia University • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
Heart drug dobutamine put to the test in rare amyloid heart disease
Knowledge-focused Recruiting nowThis early-stage trial is studying how the drug dobutamine affects the heart in 15 people with a rare condition called wild-type transthyretin amyloid cardiomyopathy (ATTRwt). Participants will receive increasing doses of dobutamine while doctors measure heart function using ultr…
Matched conditions: ATTR AMYLOIDOSIS WILD TYPE
Phase: PHASE1, PHASE2 • Sponsor: Steen Hvitfeldt Poulsen • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Heart rhythm risks in ATTR amyloidosis patients on tafamidis under scrutiny
Knowledge-focused Recruiting nowThis study follows 200 adults with ATTRwt amyloidosis who are taking tafamidis to see how often they develop heart rhythm problems that need a pacemaker or defibrillator. Researchers will also track changes in diuretic use. Participants are checked every six months as part of rou…
Matched conditions: ATTR AMYLOIDOSIS WILD TYPE
Sponsor: Paolo Milani • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC